论文部分内容阅读
为了评价干扰素、病毒唑、双黄连三药联合治疗小儿病毒性肺炎的疗效,将58例病毒性肺炎的患儿随机分为治疗组31例及对照组27例,治疗组采用干扰素肌注、病毒唑雾化吸入及双黄连静滴的方法.对照组于病毒唑单独静滴.结果治疗组总有效率明显高于对照组(x~2=7.39,P<0.01),治疗组退热时间明显短于对照组(P<0.05),平喘、止咳及肺部罗音吸收时间治疗组与对照组相比有非常显著差异(P<0.01),治疗组未见任何严重毒副作用.结果提示干扰素、病毒唑、双黄连三药联用治疗小儿病毒性肺炎为安全有效的方法.
In order to evaluate the curative effect of interferon, ribavirin and Shuanghuanglian in treating children with viral pneumonia, 58 children with viral pneumonia were randomly divided into treatment group (n = 31) and control group (n = 27). The treatment group received intramuscular injection of interferon, The treatment group were significantly higher than the control group (x ~ 2 = 7.39, P <0.01), the treatment group antipyretic time Significantly shorter than that of the control group (P <0.05), there was a significant difference between the treatment group and the control group (P <0.01), and no serious side effects were found in the treatment group. Interferon, Ribavirin, Shuanghuanglian combined with the treatment of viral pneumonia in children is safe and effective method.